Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 3 Multivariable linear regression models

From: Benzodiazepine use, quality of life and psychiatric symptom burden in oral and injectable opioid agonist treatment: a cross-sectional study

Variable

B

SE

t

p

95% CI

(Constant)

64.586

3.649

17.698

< 0.001

57.368 to 71.805

Age

− 0.051

0.076

− 0.672

0.503

− 0.201 to 0.099

Sexa

4.362

1.145

3.810

< 0.001***

2.097 to 6.626

No. of additional substances in urine

− .797

0.760

− 1.048

0.296

− 2.301 to 0.707

Psychiatric symptom load

− 1.281

1.450

− 0.883

0.379

− 4.150 to 1.588

Depressive stateb

− 0.500

0.078

− 6.390

< 0.001***

− 0.655 to − 0.345

Lifetime BZD use

− 4.544

1.720

− 2.641

0.009**

− 7.946 to − 1.141

R2 = 0.548; adjusted R2 = 0.528; n = 139;

(Constant)

61.449

3.429

17.919

< 0.001

54.665 to 68.232

Age

− 0.045

0.077

− 0.590

0.556

− 0.197 to 0.107

Sexa

4.354

1.159

3.756

< 0.001***

2.601 to 6.648

No. of additional substances in urine

− 0.444

0.778

− 0.570

0.570

− 1.982 to 1.095

Psychiatric symptom load

− 1.483

1.465

− 1.013

0.313

− 4.381 to 1.414

Depressive stateb

− 0.497

0.080

− 6.239

< 0.001***

− 0.655 to − 0.340

Current BZD use

− 2.220

1.154

− 1.924

0.057

− 4.503 to 0.063

R2 = 0.537; adjusted R2 = 0.516; n = 139;

(Constant)

61.161

3.460

17.677

< 0.001

54.317 to 68.006

Age

− 0.050

0.078

− 0.648

0.518

− 0.204 to 0.103

Sexa

4.487

1.175

3.819

< 0.001***

2.163 to 6.812

No. of additional substances in urine

− 0.570

0.783

− 0.728

0.468

− 2.118 to 0.978

Psychiatric symptom load

− 1.622

1.488

− 1.089

0.278

− 4.566 to 1.323

Depressive stateb

− 0.503

0.081

− 6.243

< 0.001***

− 0.663 to − 0.344

Prolonged BZD use

− 1.058

1.185

− 0.893

0.373

− 3.401 to 1.285

R2 = 0.532; adjusted R2 = 0.510; n = 138;

(Constant)

55.981

3.510

15.951

0.001

49.030 to 62.932

Age

0.044

0.077

0.563

0.574

− 0.110 to 0.197

Sexa

4.672

1.143

4.088

0.001***

2.408 to 6.935

No. of additional substances in urine

− 0.513

0.746

− 0.688

0.493

− 1.992 to 0.965

Psychiatric symptom load

0.824

1.489

.553

0.581

− 2.125 to 3.773

Depressive stateb

− 0.612

0.084

− 7.293

0.001***

− 0.778 to − .446

Former BZD use

1.031

1.177

0.876

0.383

− 1.301 to 3.363

R2 = 0.563; adjusted R2 = 0.540; n = 123

  1. Dependent variable: total QoL score; amale sex as reference; **indicates p < 0.01; ***indicates p < 0.001; bas measured by the ADS-L